Clinical Research & Clinical Trial Management | Project Owner

The Hidden Cost of “Fixing It Later” in Clinical Research Clinical research quality is usually discussed in the language of compliance: GCP, inspection readiness, audit findings, protocol deviations, CAPA, TMF completeness, and data integrity. This language is necessary. Clinical trials must protect participants, produce reliable results, and withstand regulatory and scientific scrutiny. A clinical trial may appear compliant at the end, but only after thousands of queries, repeated document corrections, email clarifications, monitoring follow-ups, vendor reconciliations, TMF quality-control rejections, and late-stage remediation activities. The final clinical study report may be based on acceptable data, but the operational question remains: how much rework was required to make the data, documents, and reports correct? This is where Six Sigma thinking becomes useful. Six Sigma does not need to be copied mechanically from manufacturing into clinical trials. Clinical research is more var...

As large language models (LLMs), GenAI, workflow automation, and integrated operational platforms continue to evolve, an increasingly uncomfortable question is beginning to emerge within clinical research: Why are so many additional organizational, management, and software layers still required to run clinical trials? For decades, CROs have played a central role in pharmaceutical research. Historically, this made complete sense. Pharmaceutical companies needed global operational infrastructure, therapeutic expertise, monitoring capacity, regulatory operations, staffing, laboratory services, and the ability to rapidly execute increasingly complex multinational clinical trials. However, modern clinical trial operations have also become heavily fragmented. Today, Sponsors, CROs, vendors, laboratories, and sites often maintain overlapping operational systems, duplicated reporting layers, reconciliation trackers, parallel oversight structures, and multiple disconnected software environments...

Over the last months, I have been experimenting with whether modern AI-assisted development platforms can support the creation of structured operational and budgeting systems for clinical research. One interesting experiment was the development of a simplified Clinical Trial Budget Calculator (CTBC) using the AI-assisted platform Base44 . The result is a working prototype application: https://ledger-flow-76f4f135.base44.app/ (The application currently requires free authorization via Google or email.)

Clinical trials are widely recognized as expensive and complex projects. Budget discussions usually focus on visible cost elements such as labour fees, investigator grants, site payments, vendor contracts, other passthorough. These costs are clearly documented in study budgets and contracts and are typically tracked through project accounting systems. However, the real operational cost of clinical trials often extends beyond these visible budget lines. During study execution, additional effort frequently arises from inefficient processes, fragmented systems, and operational challenges that require extra coordination by project teams. Some of this work eventually appears in project effort reports. Some of it is absorbed by organizations when project budgets are exceeded. And some effort may never be formally recorded at all. To illustrate this situation, it can be useful to distinguish between four different categories of costs in clinical trial operations: visible costs,...